Daily Archives: July 2, 2018
All three steps for Health Plus’ Go for the Gold program now available
Vanderbilt’s award-winning three-step Go for the Gold program can help you achieve a healthier and more productive life by identifying health risks and taking action to reduce those risks. Continue reading
Misoprostol Heals Small Bowel Ulcers in Aspirin Users With Small Bowel Bleeding
There is no effective treatment for aspirin-induced small bowel ulcer bleeding. We performed a double-blind, randomized, placebo-controlled trial to determine whether misoprostol can heal small bowel ulcers in patients with small bowel bleeding who req… Continue reading
Past Questions and Current Understanding About Gastric Cancer
Effects of Prebiotics vs a Diet Low in Fodmaps in Patients with Functional Gut Disorder
Prebiotics and diets low in fermentable residues (low-FODMAP diet) might reduce symptoms in patients with functional gastrointestinal disorders, despite reports that some non-absorbable, fermentable meal products (prebiotics) provide substrates for col… Continue reading
Methotrexate is not superior to placebo in maintaining steroid-free response or remission in ulcerative colitis
Parenteral methotrexate induces clinical remission but not endoscopic improvement of mucosal inflammation in patients with ulcerative colitis (UC). We performed a randomized, placebo-controlled trial to assess the efficacy of parenteral methotrexate in… Continue reading
Dysregulated bile transporters and impaired tight junctions during chronic liver injury in mice
Liver fibrosis, hepatocellular necrosis, inflammation and proliferation of liver progenitor cells are features of chronic liver injury. Mouse models have been used to study the end-stage pathophysiology of chronic liver injury. However, little is known… Continue reading
How To Approach Difficult Patient Encounters – ROAR
Targeting Enteric Glia In GI Diseases and Motility Disorders – Are we Close?
Illuminating the Black Box: The Real Risk of Serious Infection with Inflammatory Bowel Disease Therapies
Efficacies of Genotypic Resistance-guided vs Empirical Therapy for Refractory Helicobacter pylori Infection
We aimed to compare the efficacy of genotypic resistance-guided therapy vs empirical therapy for eradication of refractory H pylori infection in randomized controlled trials. Continue reading